A detailed history of Nordea Investment Management Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Nordea Investment Management Ab holds 579,022 shares of RPRX stock, worth $14.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
579,022
Previous 24,641 2249.83%
Holding current value
$14.1 Million
Previous $649,000 2423.88%
% of portfolio
0.02%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$25.63 - $29.27 $14.2 Million - $16.2 Million
554,381 Added 2249.83%
579,022 $16.4 Million
Q1 2024

May 02, 2024

BUY
$27.46 - $31.33 $54,096 - $61,720
1,970 Added 8.69%
24,641 $748,000
Q2 2023

Jul 07, 2023

BUY
$29.6 - $36.56 $19,802 - $24,458
669 Added 3.04%
22,671 $696,000
Q1 2023

Apr 19, 2023

BUY
$32.77 - $39.4 $29,886 - $35,932
912 Added 4.32%
22,002 $792,000
Q4 2022

Feb 08, 2023

SELL
$39.17 - $44.04 $33,686 - $37,874
-860 Reduced 3.92%
21,090 $833,000
Q3 2022

Oct 19, 2022

BUY
$39.88 - $44.65 $45,503 - $50,945
1,141 Added 5.48%
21,950 $889,000
Q2 2022

Aug 09, 2022

SELL
$37.53 - $44.22 $11.5 Million - $13.5 Million
-305,945 Reduced 93.63%
20,809 $865,000
Q1 2022

Apr 11, 2022

BUY
$37.46 - $42.44 $345,044 - $390,914
9,211 Added 2.9%
326,754 $12.7 Million
Q4 2021

Jan 20, 2022

BUY
$35.17 - $42.48 $6.18 Million - $7.46 Million
175,648 Added 123.79%
317,543 $12.8 Million
Q3 2021

Nov 01, 2021

SELL
$36.14 - $42.24 $5.13 Million - $5.99 Million
-141,895 Reduced 50.0%
141,895 $5.25 Million
Q3 2021

Nov 01, 2021

BUY
$36.14 - $42.24 $10 Million - $11.7 Million
277,792 Added 4631.41%
283,790 $10.3 Million
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $216,647 - $300,199
5,998 New
5,998 $300,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.